Aethlon Medical, Inc. is a San Diego-based company that specializes in addressing unmet needs in global health through the development of novel immunotherapies. Their groundbreaking technology, the Hemopurifier, is a first-in-class device designed to rapidly deplete cancer-promoting exosomes and circulating viruses in individuals with advanced or metastatic cancer who are unresponsive to standard therapies or intolerant of them. Recognized as a Breakthrough Device by the FDA, the Hemopurifier offers hope to patients with cancer types where exosomes play a role in disease development or severity, as well as those suffering from life-threatening viruses that lack approved treatments. With a focus on augmenting the body's natural immune defenses, Aethlon Medical is committed to providing innovative solutions for cancer and infectious diseases. Their mission is to combat these life-threatening conditions by leveraging their expertise in immunotherapy and advancing the Hemopurifier technology. By targeting cancer-promoting exosomes and circulating viruses, Aethlon Medical aims to improve patient outcomes and contribute to the advancement of global health.Generated from the website

Pfizer Cov X Research

Q3DM Inc

Ventrix

Neuropore Therapies Inc